Bosuvi 100 (Bosutinib 100 mg)
| Active Ingredient | Bosutinib |
|---|---|
| Manufacturers | Glenmark Pharmaceuticals Ltd. |
| Indications | blood cancer |
| Strength | 100mg |
| Packaging | 60 tablets in 1 bottle |
| Delivery Time | 6 To 15 days |
Bosuvi 100 (Bosutinib 100 mg) is a targeted cancer medication used in the treatment of chronic myeloid leukemia (CML). It belongs to a class of drugs known as tyrosine kinase inhibitors, which block cancer cell growth by interfering with specific proteins involved in cancer cell reproduction.
Bosuvi 100 is typically prescribed for patients who are newly diagnosed or those who have not responded well to other leukemia treatments. It is administered orally and should be taken exactly as prescribed by your oncologist.
Caution: Bosutinib should only be taken under strict medical supervision, and regular monitoring of liver function and blood counts is essential.








There are no reviews yet.